logo-loader
viewSourceBio International plc

SourceBio International gets set for IPO as Covid-19 testing demand becomes main focus

SourceBio International's (LON:SBI) Jay LeCoque talks to Proactive London's Katie Pilbeam ahead of their IPO on AIM.

He explains that Covid-19 is now their main focus, to support the government effort to get the pandemic testing campaign under control.

The IPO, values the company at £120m, which Jay LeCoque says is the 'right time to do it and the support from the city underscores it's the right decision to do it now.'

Quick facts: SourceBio International plc

Price: 177 GBX

AIM:SBI
Market: AIM
Market Cap: £131.3 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of SourceBio International plc named herein, including the promotion by the Company of SourceBio International plc in any Content on the Site, the...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Norman Broadbent secures new loan facility

Norman Broadbent PLC (LON:NBB), the executive search group, has strengthened its balance sheet with a £250,000 six-year CBILS loan. The funds can be drawn at any point before January 16 2021, with a 12 month interest-free period following drawdown, after which an interest rate of 4.75% per...

1 day, 3 hours ago

2 min read